Anthera Pharmaceuticals, Inc. (ANTH)

[Atlanta1]

16:02



Anthera Pharma intends to offer and sell shares of its common stock and warrants to purchase shares of its common stock in an underwritten public offering; size not disclosed (0.69 -0.01)
The Company intends to use the net proceeds from the public offering for clinical research and development purposes for SOLLPURA, including the RESULT, SIMPLICITY and EASY trials as well as enabling manufacturing and general corporate purposes.